While the molecular mechanisms of KAT2B-dependent regulation of the TGFβ pathway in COVID-19 remain to be understood we surmise host variants in KAT2B may modify disease progression and severity following SARS-CoV-2 infection. This evidence concerns the gene KAT2B and COVID-19.